Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Exogenous tap inhibitor armed oncolytic viruses and therapeutic uses thereof

Exogenous tap inhibitor armed oncolytic viruses and therapeutic uses thereof

US Patent 10232003 · Granted Mar 19, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and use2025
Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and use2022
Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and use2022
Oncolytic herpes simplex virus and therapeutic uses thereof2021
Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and use2020
Oncolytic herpes simplex virus and therapeutic uses thereof2019
Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and use2019
Oncolytic herpes simplex virus and therapeutic uses thereof2018
Oncolytic herpes simplex virus and therapeutic uses thereof2017
Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and us2017
Avirulent oncolytic herpes simplex virus strains engineered to counter the innat2014
Methods and compositions for determining the pathogenic status of infectious age2013